iSTAR Medical

📍 Wavre, Belgium🗓 Founded 2010👥 53 employees💰 Last funded Aug 2019
Medical Equipment Manufacturing🌐 istar-medical.com
Website LinkedIn
About iSTAR Medical iSTAR Medical is committed to delivering breakthrough eye care solutions. Our most advanced product, MINIject, is approved in Europe for the treatment of open-angle glaucoma – the leading cause of irreversible blindness[1] – and we are aiming to seek market approval in the US. We believe MINIject’s unique tissue-integrating capabilities unlock a safer, and more effective option for patients. We are building an exceptional team and pipeline of best-in-class products such as MINIject to establish new treatment paradigms in eye care conditions with the highest patient needs. About MINIject® MINIject is iSTAR Medical’s innovative MIGS device for patients with primary open-angle glaucoma. MINIject combines the unique porous structure of its proprietary STAR material with the power offered by the supraciliary space. As a result, it is designed to enhance natural fluid outflow, reducing intraocular pressure (IOP) and the need for medication, while bio-integrating with surrounding tissue, limiting inflammation, fibrosis and subsequent complications. About Glaucoma Glaucoma is a progressive disease affecting over 100 million people globally, of which primary open-angle glaucoma is the most common form.[1][2] IOP reduction, through medication or surgery, helps delay disease progression.[3] MIGS is the most promising and fastest-growing glaucoma therapy due to its enhanced safety profile.[2] MINIject is potentially best-in-class for its promising long-term efficacy and safety. [1] Jonas JB, Aung T, Bourne RR et al. “Glaucoma”. Lancet 2017; 390: 2083–93 [2] Market Scope, “2021 Glaucoma Surgical Device Market Report”, July 2021. https://www.market-scope.com/pages/reports/267/2021-glaucoma-surgical-device-market-report [3] “European Glaucoma Society Terminology and Guidelines for Glaucoma”, 4th Edition: British Journal of Ophthalmology. 2017;101:1-195 https://bjo.bmj.com/content/101/5/73 MINIject is a registered trademark in the European Union.
5
Total investors
0
Early stage
2
Mid stage
3
Late stage
2010
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Belgium
3
Switzerland
1
Netherlands
1
Investor activity2013–2019 · investors recorded per year
2013220193
Recent (last 2y)Earlier
Frequently asked questions
Who invested in iSTAR Medical?
iSTAR Medical has 5 investors on record on gritt.io, 2 mid-stage and 3 late-stage investors.
When did iSTAR Medical last raise funding?
The most recent investment in iSTAR Medical recorded on gritt.io was in August 2019.
When was iSTAR Medical founded?
iSTAR Medical was founded in 2010.
What industry is iSTAR Medical in?
iSTAR Medical operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is iSTAR Medical based?
iSTAR Medical is headquartered in Wavre, Belgium.